Skip to main content
NCBI home page
Tobacco Control logoLink to Tobacco Control
. 2005 Oct;14(5):346–355. doi: 10.1136/tc.2004.009183

Characteristics of selectors of nicotine replacement therapy

S Shiffman 1, M Di 1, C Sweeney 1
PMCID: PMC1748094  PMID: 16183986

Abstract

Objective: To assess differences in demographic and smoking characteristics between smokers who have and have not used nicotine replacement therapy (NRT).

Design: Mail survey of US smokers from a national research panel.

Participants: Smokers 18 years and over who returned a survey on smoking (n = 9630). The sample was weighted to match the US smoker population on age and sex.

Main outcome measures: Compared smokers who had/had not used NRT in a quit attempt (ever NRT use or over the counter (OTC) NRT use) on: demographic characteristics, nicotine dependence, history of craving and withdrawal, expected difficulty quitting, and self reported history of smoking related medical illness and psychopathology.

Results: NRT users (both ever-users and OTC users) were more likely to be older, male, and better educated. They were also heavier smokers, had experienced more craving and withdrawal upon quitting, and scored higher on measures of dependence. These differences were evident among light smokers, and remained even when smoking rate and time to first cigarette were controlled.

Conclusion: Smokers who elect to use NRT differ from non-NRT users in ways that predispose them to failure in cessation. Controlling for smoking rate and time to first cigarette does not eliminate these differences, even among light smokers. These differences must be considered when comparing the effectiveness of NRT among samples of smokers who self select their treatment and are likely to bias such outcome comparisons.

Full Text

The Full Text of this article is available as a PDF (111.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burton S. L., Gitchell J. G., Shiffman S., Centers for Disease Control and Prevention (CDC) Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998. MMWR Morb Mortal Wkly Rep. 2000 Jul 28;49(29):665–668. [PubMed] [Google Scholar]
  2. Cummings K. M., Hyland A., Ockene J. K., Hymowitz N., Manley M. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tob Control. 1997;6 (Suppl 2):S63–S70. doi: 10.1136/tc.6.suppl_2.s63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fagerstrom K. O., Schneider N. G. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989 Apr;12(2):159–182. doi: 10.1007/BF00846549. [DOI] [PubMed] [Google Scholar]
  4. Glassman A. H., Helzer J. E., Covey L. S., Cottler L. B., Stetner F., Tipp J. E., Johnson J. Smoking, smoking cessation, and major depression. JAMA. 1990 Sep 26;264(12):1546–1549. [PubMed] [Google Scholar]
  5. Haxby D., Sinclair A., Eiff M. P., McQueen M. H., Toffler W. L. Characteristics and perceptions of nicotine patch users. J Fam Pract. 1994 May;38(5):459–464. [PubMed] [Google Scholar]
  6. Heatherton T. F., Kozlowski L. T., Frecker R. C., Fagerström K. O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x. [DOI] [PubMed] [Google Scholar]
  7. Heatherton T. F., Kozlowski L. T., Frecker R. C., Rickert W., Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989 Jul;84(7):791–799. doi: 10.1111/j.1360-0443.1989.tb03059.x. [DOI] [PubMed] [Google Scholar]
  8. Hill H. A., Schoenbach V. J., Kleinbaum D. G., Strecher V. J., Orleans C. T., Gebski V. J., Kaplan B. H. A longitudinal analysis of predictors of quitting smoking among participants in a self-help intervention trial. Addict Behav. 1994 Mar-Apr;19(2):159–173. doi: 10.1016/0306-4603(94)90040-x. [DOI] [PubMed] [Google Scholar]
  9. Hughes J. R., Shiffman S., Callas P., Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003 Mar;12(1):21–27. doi: 10.1136/tc.12.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hughes John R., Keely Josue, Naud Shelly. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004 Jan;99(1):29–38. doi: 10.1111/j.1360-0443.2004.00540.x. [DOI] [PubMed] [Google Scholar]
  11. Hymowitz N., Cummings K. M., Hyland A., Lynn W. R., Pechacek T. F., Hartwell T. D. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6 (Suppl 2):S57–S62. doi: 10.1136/tc.6.suppl_2.s57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson R. E., Stevens V. J., Hollis J. F., Woodson G. T. Nicotine chewing gum use in the outpatient care setting. J Fam Pract. 1992 Jan;34(1):61–65. [PubMed] [Google Scholar]
  13. Killen J. D., Fortmann S. P. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol. 1997 May;5(2):137–142. doi: 10.1037//1064-1297.5.2.137. [DOI] [PubMed] [Google Scholar]
  14. Klungel Olaf H., Martens Edwin P., Psaty Bruce M., Grobbee Diederik E., Sullivan Sean D., Stricker Bruno H. Ch, Leufkens Hubert G. M., de Boer A. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol. 2004 Dec;57(12):1223–1231. doi: 10.1016/j.jclinepi.2004.03.011. [DOI] [PubMed] [Google Scholar]
  15. Lasser K., Boyd J. W., Woolhandler S., Himmelstein D. U., McCormick D., Bor D. H. Smoking and mental illness: A population-based prevalence study. JAMA. 2000 Nov 22;284(20):2606–2610. doi: 10.1001/jama.284.20.2606. [DOI] [PubMed] [Google Scholar]
  16. Matheny K. B., Weatherman K. E. Predictors of smoking cessation and maintenance. J Clin Psychol. 1998 Feb;54(2):223–235. doi: 10.1002/(sici)1097-4679(199802)54:2<223::aid-jclp12>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Mokdad Ali H., Marks James S., Stroup Donna F., Gerberding Julie L. Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238–1245. doi: 10.1001/jama.291.10.1238. [DOI] [PubMed] [Google Scholar]
  18. Monsó E., Campbell J., Tønnesen P., Gustavsson G., Morera J. Sociodemographic predictors of success in smoking intervention. Tob Control. 2001 Jun;10(2):165–169. doi: 10.1136/tc.10.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ness Roberta B., Cauley Jane A. Antibiotics and breast cancer--what's the meaning of this? JAMA. 2004 Feb 18;291(7):880–881. doi: 10.1001/jama.291.7.880. [DOI] [PubMed] [Google Scholar]
  20. Nides M. A., Rakos R. F., Gonzales D., Murray R. P., Tashkin D. P., Bjornson-Benson W. M., Lindgren P., Connett J. E. Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol. 1995 Feb;63(1):60–69. doi: 10.1037//0022-006x.63.1.60. [DOI] [PubMed] [Google Scholar]
  21. Nordstrom B. L., Kinnunen T., Utman C. H., Krall E. A., Vokonas P. S., Garvey A. J. Predictors of continued smoking over 25 years of follow-up in the normative aging study. Am J Public Health. 2000 Mar;90(3):404–406. doi: 10.2105/ajph.90.3.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Orleans C. T., Resch N., Noll E., Keintz M. K., Rimer B. K., Brown T. V., Snedden T. M. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. JAMA. 1994 Feb 23;271(8):601–607. [PubMed] [Google Scholar]
  23. Pierce John P., Gilpin Elizabeth A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA. 2002 Sep 11;288(10):1260–1264. doi: 10.1001/jama.288.10.1260. [DOI] [PubMed] [Google Scholar]
  24. Pinto R. P., Abrams D. B., Monti P. M., Jacobus S. I. Nicotine dependence and likelihood of quitting smoking. Addict Behav. 1987;12(4):371–374. doi: 10.1016/0306-4603(87)90052-9. [DOI] [PubMed] [Google Scholar]
  25. Rockwood Kenneth, Kirkland Susan, Hogan David B., MacKnight Chris, Merry Heather, Verreault René, Wolfson Christina, McDowell Ian. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002 Feb;59(2):223–227. doi: 10.1001/archneur.59.2.223. [DOI] [PubMed] [Google Scholar]
  26. Shiffman S., Gitchell J., Pinney J. M., Burton S. L., Kemper K. E., Lara E. A. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997 Winter;6(4):306–310. doi: 10.1136/tc.6.4.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Shiffman S., Paton S. M. Individual differences in smoking: gender and nicotine addiction. Nicotine Tob Res. 1999;1 (Suppl 2):S153–S166. doi: 10.1080/14622299050011991. [DOI] [PubMed] [Google Scholar]
  28. Shiffman Saul, Dresler Carolyn M., Hajek Peter, Gilburt Simon J. A., Targett Darren A., Strahs Kenneth R. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med. 2002 Jun 10;162(11):1267–1276. doi: 10.1001/archinte.162.11.1267. [DOI] [PubMed] [Google Scholar]
  29. Shiffman Saul. Nicotine lozenge efficacy in light smokers. Drug Alcohol Depend. 2005 Mar 7;77(3):311–314. doi: 10.1016/j.drugalcdep.2004.08.026. [DOI] [PubMed] [Google Scholar]
  30. Shiffman Saul, Waters Andrew, Hickcox Mary. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004 Apr;6(2):327–348. doi: 10.1080/1462220042000202481. [DOI] [PubMed] [Google Scholar]
  31. Stuart K., Borland R., McMurray N. Self-efficacy, health locus of control, and smoking cessation. Addict Behav. 1994 Jan-Feb;19(1):1–12. doi: 10.1016/0306-4603(94)90046-9. [DOI] [PubMed] [Google Scholar]
  32. West R. J., Hajek P., Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med. 1989 Nov;19(4):981–985. doi: 10.1017/s0033291700005705. [DOI] [PubMed] [Google Scholar]
  33. Zhu S., Melcer T., Sun J., Rosbrook B., Pierce J. P. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000 May;18(4):305–311. doi: 10.1016/s0749-3797(00)00124-0. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES